News

Advarra continues its commitment to the research community with more opportunities for education and collaboration. Read more:

Advarra’s US offices will be closed on Monday, May 25. The IRB and IBC will not meet on Monday, May 25.

Advarra’s Canada offices will be closed on Monday, May 18.

BBK Worldwide interviewed Advarra Chief Compliance Officer and Institutional Official for a special COVID-19 edition of its Pharma15 Live! Video series.

Advarra has been added to a COVID-19 Research Database, a pro bono, cross-industry collaboration.

Science 37, the industry leader in decentralized clinical trials, and Advarra, a leading institutional review board (IRB), have partnered to expedite approvals on COVID-19–related virtual trials.

Advarra is pleased to announce the acquisition of IRBco, an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981.

Advarra announced today the appointment of Gadi Saarony as Chief Executive Officer.

Advarra today shared progress made by customers utilizing the company’s products and services to keep research moving forward during the COVID-19 pandemic.

Due to the upcoming Good Friday holiday, some review timelines have been modified.

ACRP recognized Advarra for the organization’s leadership and free guidance during the global COVID-19 pandemic in the blog article Clinical Trial Leaders Offer Free Resources to Battle COVID-19.

In response to the current COVID-19 public health emergency, Health Canada has published the notification Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors.